Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice

Stem Cells

Volumn 30, Issue 12, 2012, Pages 2692-2699

  Sun, Yue Qi ^a   Deng, Meng Xia ^a   He, Jia ^b   Zeng, Qing Xiang ^a   Wen, Weiping ^a   Wong, David S H ^b   Tse, Hung Fat ^b   Xu, Geng ^a   Lian, Qizhou ^b   Shi, Jianbo ^a   Fu, Qing Ling ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allergy; Immunomodulation; Induced pluripotent stem cells; Mesenchymal stem cells

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCUS; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; LOWER RESPIRATORY TRACT; LUNG LAVAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; NOSE MUCUS; PLURIPOTENT STEM CELL; SENSITIZATION; TH2 CELL; UPPER RESPIRATORY TRACT;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; IMMUNOTHERAPY, ADOPTIVE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; NASAL CAVITY; PLURIPOTENT STEM CELLS; TH2 CELLS;

ANIMALIA; MUS;

EID: 84870362545     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1241     Document Type: Article

References (41)

1. Singer NG, Caplan AI. Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol 2011;6:457-478.
2. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-736.
3. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol 2007;28:219-226.
4. Keating A. Mesenchymal stromal cells: New directions. Cell Stem Cell 2012;10:709-716.
5. Wagner W, Bork S, Horn P et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009;4:e5846.
6. Crisostomo PR, Wang M, Wairiuko GM et al. High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 2006;26:575-580.
7. Kretlow JD, Jin YQ, Liu W et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008;9:60.
8. Heeschen C, Lehmann R, Honold J et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-1622.
9. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 2008;314:1937-1944.
10. Lian Q, Zhang Y, Zhang J et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010;121:1113-1123.
11. Giuliani M, Oudrhiri N, Noman ZM et al. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood 2011;118:3254-3262.
12. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, Ga(2)Len And Allergen) Allergy2008;63 (suppl 86):8-160.
13. Eder W, Ege MJ, von ME. The asthma epidemic. N Engl J Med 2006;355:2226-2235.
14. Gerez IF, Lee BW, van Bever HP et al. Allergies in Asia: Differences in prevalence and management compared with western populations. Expert Rev Clin Immunol 2010;6:279-289.
15. Compalati E, Ridolo E, Passalacqua G et al. The link between allergic rhinitis and asthma: The united airways disease. Expert Rev Clin Immunol 2010;6:413-423.
16. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445-454.
17. Goodwin M, Sueblinvong V, Eisenhauer P et al. Bone marrow-derived mesenchymal stromal cells inhibit th2-mediated allergic airways inflammation in mice. Stem Cells 2011;29:1137-1148.
18. Nemeth K, Keane-Myers A, Brown JM et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010;107:5652-5657.
19. Bonfield TL, Koloze M, Lennon DP et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010;299:L760-L770.
20. Bonfield TL, Nolan Koloze MT, Lennon DP et al. Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond) 2010;7:51.
21. Cho KS, Roh HJ. Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Curr Stem Cell Res Ther 2010;5:111-115.
22. Cho KS, Park HK, Park HY et al. IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 2009;27:259-265.
23. Fu QL, Chow YY, Sun SJ et al. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy 2012;67:1215-1222.
24. Zhang J, Lian Q, Zhu G et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011;8:31-45.
25. Lian Q, Lye E, Suan YK et al. Derivation of clinically compliant MSCs from CD105+. Stem Cells 2007;25:425-436.
26. Hellings PW, Hessel EM, Van Den Oord JJ et al. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy 2001;31:782-790.
27. Yokota E, Kuyama S, Ogawa M et al. Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice. Int Immunopharmacol 2008;8:1083-1088.
28. Kang JH, Kim BS, Uhm TG et al. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. Am J Respir Crit Care Med 2009;179:875-882.
29. Tournoy KG, Kips JC, Schou C et al. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 2000;30:79-85.
30. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 2011;66:523-531.
31. Firinci F, Karaman M, Baran Y et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011;11:1120-1126.
32. Su WR, Zhang QZ, Shi SH et al. Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms. Stem Cells 2011;29:1849-1860.
33. Broide DH, Finkelman F, Bochner BS et al. Advances in mechanisms of asthma, allergy, and immunology in 2010. J Allergy Clin Immunol 2011;127:689-695.
34. Glennie S, Soeiro I, Dyson PJ et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005;105:2821-2827.
35. Brown JM, Nemeth K, Kushnir-Sukhov NM et al. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy 2011;41:526-534.
36. Zhang Y, Liao S, Yang M et al. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplant. 2012 Jul 5. [Epub ahead of print].
37. Sun L, Akiyama K, Zhang H et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009;27:1421-1432.
38. Zhou K, Zhang H, Jin O et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008;5:417-424.
39. Gruenloh W, Kambal A, Sondergaard C et al. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A 2011;17:1517-1525.
40. Lister R, Pelizzola M, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011;471:68-73.
41. Laurent LC, Ulitsky I, Slavin et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011;8:106-118.